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Abstract: There is a lack of dietitians trained to deliver the low fermentable oligosaccharides,
disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD) for irritable bowel syndrome (IBS).
Many patients receive nutritional information from general practitioners (GPs) or gastroenterologists
(GEs). Since the LFD is dietitian-led, the aim of this research was to qualitatively explore the effects
of GP- and GE-delivered LFD information, in IBS self-management. Semi-structured interviews
were conducted in a purposive sample of 8 people with IBS (6 female), who used the LFD as their
primary treatment. Interpretive Phenomenological Analysis (IPA) was used to develop themes on the
lived experience of the participant’s use of LFD information from GPs and GEs. This information
was perceived as trustworthy but simplistic; often just ”food lists” with little personalisation to
meet individual needs and difficult to apply in ”real life”. The information required substantial
interpretation and the familial and social effects of implementation were not addressed in the materials
provided. Supplementary digital resources were regarded as more practical but the participants
expressed concern in relation to the validity of these materials. The findings in this study support
current clinical guidelines proposed by both the National Institute for Health and Care Excellence and
the British Dietetic Association that the LFD should be considered a dietitian-led only intervention.
Keywords: irritable bowel syndrome; low FODMAP diet; education delivery; nutritional information
1. Introduction
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that manifests with
symptoms of abdominal pain and altered bowel habit in the absence of abnormal findings on routine
clinical tests explaining the symptoms [1].
The world-wide prevalence of IBS is 11.2% [2]. Patients with IBS have a significantly lower
quality of life, and the economic and societal costs associated with IBS are also considerable [3–5].
Currently, the medical treatment of IBS is considered suboptimal and its pathophysiology is poorly
understood [6]. It is thought that IBS results from abnormalities of the “gut–brain axis” (a bidirectional
circuit of communication between the gut and the brain) that may involve both mucosal and
neuro-inflammation [6–11]. Nutrition appears to play an important role in IBS, both in exacerbating
(approximately 60% of patients) or providing relief of symptoms [12–16].
Over the last 10 years, dietary research has focused on the role of fermentable oligo-, di-, and
mono-saccharides and polyols (FODMAPs) in relation to the induction of IBS symptoms. A substantial
body of research has demonstrated the effectiveness of reducing dietary FODMAPs in treating IBS
symptomology [17–21]. Both the National Institute for Health and Care Excellence (NICE) and the
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British Dietetic Association (BDA) have adopted the low FODMAP diet (LFD) into their guidelines
for treatment of IBS. These guidelines emphasise the need for this approach to be delivered by a
clinician/therapist who has both the necessary experience and expertise [22,23]. Thus, best practice
necessitates patients who may benefit from a LFD being assessed and supported by a specialist
registered dietitian (RD) with specific training in the approach [24].
The LFD is a complex three stage nutrition intervention; FODMAP restriction, reintroduction and
personalisation. Specialist dietitian support ensures the approach is tailored to patients’ specific dietary
needs, adequate follow-up is provided to assess its effectiveness, and FODMAPs are reintroduced to
individual tolerance; thus minimising the potential risks [24–27]. These risks include alteration of
the gut microbiome (specifically a reduction in the relative abundance of beneficial bifidobacteria), a
reduction in dietary calcium intake and potential precipitation of disordered eating, such as orthorexia
or anorexia nervosa [28–34].
Dietetic counselling is a central component of the research demonstrating the efficacy of the
LFD [35–37]. This includes supporting patients to self-manage the practical application of the approach
with up-to-date information and appropriate resources, including written dietary information, digital
applications and online material [24,25,27]. Evidence-based guidelines for the production of effective
patient information exist (see Table 1) [38–40]. These emphasise the importance of utilising current
research and ensuring service users are integral to the development of the materials.
Table 1. Components in the Production of Effective Patient Information.
• Information based on current/up-to-date literature.
• Communicated in a format that patients can understand and apply.
• Information provided in a variety of formats.
• Service users involved in both the production and evolution of materials.
However, due to the increasing awareness of the LFD and a lack of suitably trained dietitians
there is growing anecdotal evidence that both general practitioners (GPs) and gastroenterologists
(GEs) provide patients with basic low FODMAP information [24]. Such information is often presented
in the form of simple one-page lists of foods to include and avoid. Delivery of LFD information in
this format has been described as deviation from best practice [41]. The aim of this research was
to qualitatively explore the lived experience of how people with IBS use and apply LFD nutritional
information provided by GPs and GEs to self-manage their symptoms.
2. Materials and Methods
2.1. Choice of Methodology
A qualitative research methodology, specifically Interpretive Phenomenological Analysis (IPA)
was employed. IPA utilises phenomenological, hermeneutic and idiographic techniques to understand
“how people ascribe meaning to their experiences in their interactions with their environment” [42].
As a functional illness the experience of IBS is highly individual and subjective in its manifestation [43].
People with IBS have vastly different experiences in their diagnostic and treatment journeys, with
the somatic components of IBS inherently requiring individual interpretation [44]. Therefore, IPA is
particularly suited to explore this study’s research question aiming to understand how people with IBS
make sense of the dietary information they use and what this means in relation to the self-management
of their symptoms [45]. A distinctive feature of IPA is its commitment to depth of analysis, and it
aims to provide a detailed account of individual cases and therefore inherently requires small sample
sizes [46].
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2.2. Recruitment
A purposive, non-probability, sampling approach was used, that aimed to recruit individuals
who could provide detailed information on the “lived experience” of using dietary information on
the low FODMAP diet provided by GPs and GEs [47]. The participants were similar to other IBS
cohorts in that they were predominately female and under 50 years of age. All participants in this
study were medically diagnosed with IBS (5 via their GP and 3 via a gastroenterologist) and the
principle investigator (PI) confirmed their diagnosis in reference to ROME III guidelines prior to their
participation. Participants were provided with an information sheet before being interviewed and
written consent was obtained.
2.3. Data Collection
To capture the participants’ experiences of using LFD information from GPs and GEs,
semi-structured interviews were conducted by the PI. An interview schedule was produced based on
perspectives highlighted from a review of the current literature, on information delivery in IBS and
self-management strategies [48]. The phrasing and order of questions was iterative and developed over
the interviewing process [49]. With the participant’s permission all the interviews were audio-recorded,
and direct verbatim transcripts were produced. Interviews were conducted in a quiet room booked
specifically for the purpose of a private, relaxed and uncluttered space likely to encourage rapport and
dialogue [50].
Through discussions with clinical colleagues and the maintenance of a reflective journal, the PI
attempted to bracket their own cognitions and affects in relation to the participants, during the data
collection phase.
2.4. Data Analysis
IPA requires an iterative four-step process that includes an initial close reading and in-depth
analysis of each interview transcript; noting reoccurring phrases, associations and any contradictions
within the text [51]. To ensure maximal engagement with the data both the audio recordings and
written transcripts of the interviews were revisited a number of times [42].
From this, emergent themes were developed, noting any possible interconnections. This process
was facilitated by the use of different framing techniques including abstraction, contextualisation,
polarisation and function. These formed a basis for the superordinate categories and related themes;
the transcripts were frequently referred to during each stage of this activity; to further ensure the
interpretative process reflected what the participant had actually said [52].
Finally, these results were ordered onto a diagram (see Figure 1) that summarises the superordinate
themes, representing shared higher order qualities, and associated subordinate themes, along with
relevant quotations that situate them in the participants’ actual experience [42,46].
Ethical approval was granted for this research study by the Human Ethics Committee at the
University of Sheffield (approval number 012414).
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Figure 1. Patient use of low fermentable oligosaccharides, disaccharides, monosaccharides and polyols
(low FODMAP) dietary information provided by general practitioners and gastroenterologists.
3. Results
The purposive sample strategy initially recruited 14 participants. Upon interview it emerged that
for 4 participants the LFD was not the primary treatment for their IBS, so along with two initial pilot
interviews they were excluded from the analysis. All participants were either Sheffield University
staff (lecturers and support staff) or under- and post-graduate students. Participants’ characteristics,
including age, gender and diagnosis, are summarised (see Table 2), with the acronyms P1 to P8 being
used to maintain confidentiality.
Table 2. Characteristics of participants.
Participants Age Gender Ethnic Origin IBS Type
Length of Diagnosis
(Years)
P1 24 Female White British IBS-D 4
P2 54 Female White British IBS-D 20
P3 28 Female White British IBS-D 1
P4 48 Male White British IBS-D 2
P5 28 Female White British IBS-D 4
P6 64 Male White British IBS-D 40
P7 33 Female White British IBS-C 6
P8 43 Female White British IBS-C 15
Diarrhoea predominant, was the most common IBS diagnosis amongst the cohort. The mean
length of diagnosis was approximately 11 years (range 1–40 years). Six of the participants were female.
All participants had received dietary information from either GPs or GEs supplemented with material
from online searching.
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3.1. Validity of Information
This was an overarching theme, recurrently emphasised by the participants. It related to an
evident need to have accurate dietary information that made sense to the participants in relation to
their symptoms. Information from GPs and GEs was viewed with a high degree of trust. However, the
nutritional information received was equally often seen as inadequate or incomplete.
3.1.1. Information from General Practitioners and Gastroenterologists Trusted but Simplistic
The participants reported a feeling of superficiality in relation to the dietary information
provided by GP/GEs, the information was seen as very uniform and there was little indication
of any personalisation to meet individual needs of the participants:
“ . . . it’s IBS you can ‘Google’ it but it probably won’t change anything, that was sort of
what he said.” [P3]
There seems to have been some recognition of this by the GP/GEs, but participants were merely
encouraged to assess additional material themselves. This suggests GP/GEs saw dietary information
as prescriptive; advice was often reductive with blanket “allowed” and “avoid” ingredient lists:
“ . . . um it was printed for me given to me and was told to go and have a look and do a
bit of research yourself. It was just a couple of sheets of like really simple, just kind of
um like no’s and yes’s . . . really foods to avoid . . . ” [P4]
3.1.2. Supplementary Digital Sources Used, but Not Trusted
All the participants had supplemented the dietary information they had received from GP/GEs
with digital and online resources. They often spent a significant amount of time trying to source
nutritional information that had more relevance for their day to day experience:
“ . . . I think yeah, having confidence in the information was the important thing, having
had that information [FODMAP App] that changed the way I eat, it has made a terrific
difference.” [P2]
However as potential sources of information the participants expressed concern in relation to the
validity of the material obtained in peer-to-peer forums. This sometimes generated a sense of distrust
and could inhibit or prevent involvement with such groups:
“ . . . Erm, I never went into more like the chat side, just more like the NHS side, you feel
like you can trust it a bit more” [P3]
3.2. Burden of Use of Information
This theme shadowed the participants’ sense that the dietary information they used, was in some
ways incomplete. Many participants felt that information obtained from both GP/GEs and online
required a process of adaption, expansion and translation to make them more personal and realistic.
The resulting restrictions were often viewed as contradicting what was understood as “healthy eating”,
which was again seen as an issue not addressed in the dietary information provided by GP/GEs. These
issues resulted in some participants seeing the suggested alterations to their dietary habits as not just
impractical but beyond the limits of their personal agency.
3.2.1. Interpretation of Information Increased Burden
A common sentiment expressed by the participants centred around the dietary advice they
received being often highly binary in nature, amounting to little more than “Yes/No” lists of foods.
These lists were often perceived by the participants as just ingredients and did not relate to the way
that they bought or consumed foods. There was no consideration of processed branded goods, food
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preparation, and the economic impact of the suggested dietary approaches. This was highlighted by a
participant contrasting her experience with a weight loss programme:
“ . . . suggestions like this is a breakfast, this is a lunch . . . just some ideas of, like . . . you
know that what happens with [weight loss programme] for example you don’t just get the
list of foods . . . you get recipes and lots of things . . . like they do things on a budget and
you just click on line and find out these things, but it was difficult to find these FODMAP
foods.” [P1]
This created an additional burden to implementing the LFD. A further complication of needing to
supplement the initial material was that participants reported a sense of information overload. This
was particularly true when participants sort clarification and additional advice online:
“ . . . when you went online, . . . seems to be, it’s a bit like . . . you know, a sea of information
. . . ” [P8]
3.2.2. Concerns on Health of Dietary Treatment
Participants often expressed feeling there was a contradiction between the information they
received from GP/GEs and what they understood as a healthy diet. This again related to what the
participants felt was a lack of personalisation in the information on the LFD:
“ . . . you know, a big thing like was the lack of fibre . . . I was just like, I don’t think I’m
willing to sacrifice . . . my diet and my healthy eating for the symptoms.” [P5]
However, interestingly for some participants the imposed limitations caused them to be more
intentional in relation to their food purchases and meal preparation. Although this was not necessarily
understood as having a positive consequence, in terms of its impact on the participants social life:
“ . . . when you’re out it’s very very hard and when you’re buying products, erm, so I
think the solution is to eat as little processed food as possible.” [P6]
3.2.3. Limits of Personal Agency Not Addressed or Acknowledged
Concerns of the effect of dietary changes on health, the need to adapt information and continually
monitor their “nutritional landscape” resulted in some participants questioning their ability to maintain
potentially beneficial nutritional modifications over the longer term:
“But did I find it a problem doing it..erm, I think my one, my one recollection was just
thinking ‘oh my God it’s so bloody exhaustive . . . ” [P4]
The participants awareness of the limits of their personal agency (around the use and application
of dietary information from GP/GEs) appeared to contribute to their sense of restricted volition.
Maintenance of a LFD was seen as unrealistic for some participants. They felt the information
they received lacked both nuance in addressing their concerns and acknowledging how difficult the
approach could be:
“ . . . what can I do . . . it was difficult . . . yeah so the time and the expense as well, things
that I maybe wouldn’t have bought before and you know because a lot of the stuff is not
cheap or easy to make meals so yeah the expense of it planning it and yeah just like going
out of your normal routine . . . ” [P1]
3.3. Effects on Food Related Quality of Life
This theme related to the dissidence participants experienced between using LFD information
from GP/GEs for IBS symptom management and its effects on the social and cultural roles of food. The
maintenance of social activities that centred on eating and drinking were more problematic and this
had a negative impact on family dynamics.
Nutrients 2019, 11, 1313 7 of 12
3.3.1. Partner and Family Burden
Participants related that family roles involving food were altered or lost. Nutritional behaviours
that symbolised care and mutual affection were absent or changed and this impacted both the
participants and their partners:
“The burden mainly fell on my partner who suddenly found, that many of the things that
she liked eating I wasn’t cooking anymore.” [P6]
“ . . . the impact with my partner has been that we can’t share cakes . . . that’s one thing
we used to do, we’d go out and have coffee and half a cake each . . . ” [P2]
3.3.2. Social Effects of Dietary Treatment
Beyond immediate family members there were wider social effects of implementing LFD advice.
Again, what emerged was that the information participants had received appeared to not take into
account the implications and outcomes on the participants’ wider sense of community:
“ . . . and you feel an incredible pain because people invite you to dinner and . . . my
friends are really great about this, but FODMAP is complicated.” [P6]
“ . . . there was an element of, oh my gosh, if I have to stick to this a hundred percent I
am regimented. I am not going to have a life” [P1]
The information the participants received did not address or acknowledge these social effects
such as the sense of being “othered” and needing to repeatedly defend their food choices:
“ . . . so I’m always being ‘sorry’ I’m the difficult one that needs something special . . .
” [P1]
4. Discussion
A recent meta-analysis concluded that “ . . . there is very low quality evidence that a low FODMAP
diet is effective in reducing symptoms in adult IBS patients”. Issues raised included inappropriate
comparator placebo arms, lack of blinding, short trial duration, and small patient cohorts [53]. However,
the practice of providing basic printed literature on the LFD by GP/GEs is anecdotally recognised
as widespread across the UK [24]. This pattern may have occurred as a result of insufficient dietetic
support within the UK National Health Service but is not the current recommendation of existing
guidelines, which recognise that the LFD is a complex elimination diet comprising three specific
integrated stages [22,23]. We wonder if this practice results in reduced levels of effectiveness for this
dietary intervention and reduced long-term adoption or adherence rates. This is the first study to use
qualitative semi-structured interviews to explore and develop key themes on the lived experience of
IBS patients being provided low FODMAP diet information from GPs and GEs.
The validity of information was important for the participants, with materials from GP/GEs being
valued as a “trusted source”. However, this information was viewed as being overly simplistic, often
just “food lists” with little or no personalisation to meet participants individual needs and this reduced
its utility. Guidelines for the production of effective health information have been established and
published [38–40]. This requires health information to be based on current literature and communicated
in a format that patients can understand and apply; this may entail producing the information in a
variety of formats. Service users should be involved in both the production and evolution of such
materials through activities such as focus groups that encourage user testing [54]. It appeared the
majority of the LFD information provided to the participants in this study had not been produced in
line with the above recommendations.
As a consequence, the participants supplemented the information provided by GP/GEs with
digital material. This was viewed as more practical, in terms of application in daily life, but equally
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was regarded as burdensome. It required a substantial commitment of time and often concerns were
raised amongst the participants as to the validity of the information they accessed online.
The participants also voiced concerns in relation to the potential negative health effects of
implementing the LFD information provided to them. Although a dietitian-led LFD broadly maintains
nutrient and fibre intake, participants felt applying the materials presented to them would likely reduce
the nutritional quality of their diets. Equally the elimination phase of the LFD may have detrimental
effects on the human microbiome and none of the participants in this study reported being provided
specific advice for the re-introduction of higher FODMAP foods to tolerance [25,55,56].
All the participants in this study re-counted negative effects of applying the LFD information
on their family and social life. The act of cooking and sharing meals has been acknowledged as
an important aspect of food related quality of life and family roles involving food were altered or
diminished [57]. Participants described applying LFD information resulted in considerable partner
burden, which is recognised in the IBS literature. Dietary interventions for IBS should aim to include
partners and/or next of kin with measures to help them understand the treatment modalities [58].
Beyond immediate family members the social effects of using LFD information appeared to
accentuate the participants sense of being excluded from communal events involving food. There
was a sense that such events needed to be navigated rather then enjoyed. This again highlights the
importance of LFD information being positioned contextually within the wider framework of an IBS
sufferer’s life. Specifically, nutritional information resources that do not offer strategies of how to
navigate familial and societal roles while altering dietary intake are unlikely to succeed [25].
There are several limitations to this study. As the aims of the study were to obtain in-depth
data on the experience of the specific participants recruited, the findings cannot be generalised to the
wider IBS population. Equally all the participants recruited were caucasian British university staff
or students. Therefore inherently the experiences described, analysed and presented in the results
represent a particular socio-economic demographic. Futures studies should aim to recruit from a wider
range of ethnic and social backgrounds, as this would help contribute to a greater understanding of
patient needs for dietary information in implementing the LFD.
In conclusion, this is the first study to explore the lived experience of IBS patients being provided
low FODMAP diet information from GPs and GEs. The patients reported that the information provided
was difficult to apply in “real life”. Further work is required to quantify the size of this problem.
If this approach is occurring organically within the UK due to economic restraints then alternative
delivery methods should be explored—such as dietitian-led low FODMAP group education, digital
applications and online webinars could be developed further to support this group of patients [59–61].
Patients must be involved in both the production and evolution of such materials and approaches,
through activities such as focus groups that encourage user testing. The findings in this study support
current clinical guidelines proposed by the both by NICE and the BDA that the LFD should still be
considered a second-line, dietitian-led only intervention.
Author Contributions: Conceptualization, N.T. and D.S.S.; formal analysis, N.T.; investigation, N.T.; methodology,
N.T.; supervision, I.A. and D.S.; writing—original draft, N.T.; writing—review and editing, I.A., A.R. and D.S.S.
Funding: No funding was obtained for this study.
Acknowledgments: The authors would like to acknowledge the support of Sharon Elliott for her support in
facilitating data collection in this study.
Conflicts of Interest: The authors declare no conflicts of interest.
Nutrients 2019, 11, 1313 9 of 12
References
1. Lacy, B.E.; Mearin, F.; Chang, L.; Chey, W.D.; Lembo, A.J.; Simren, M.; Spiller, R. Bowel disorders.
Gastroenterology 2016, 150, 1393–1407.e5. [CrossRef] [PubMed]
2. Canavan, C.; West, J.; Card, T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014, 6, 71–80.
[PubMed]
3. Whitehead, W.E.; Palsson, O.; Jones, K.R. Systematic review of the comorbidity of irritable bowel syndrome
with other disorders: What are the causes and implications? Gastroenterology 2002, 122, 1140–1156. [CrossRef]
[PubMed]
4. Akehurst, R.L.; Brazier, J.E.; Mathers, N.; O’Keefe, C.; Kaltenthaler, E.; Morgan, A.; Platts, M.; Walters, S.J.
Health-Related Quality of Life and Cost Impact of Irritable Bowel Syndrome in a UK Primary Care Setting.
Pharmacoeconomics 2002, 2002, 455–462. [CrossRef] [PubMed]
5. Ford, A.C.; Bercik, P.; Morgan, D.G.; Bolino, C.; Pintos–Sanchez, M.I.; Moayyedi, P. Validation of the Rome III
criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013, 145, 1262–1270.
[CrossRef] [PubMed]
6. Holtmann, G.J.; Ford, A.C.; Talley, N.J. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol.
Hepatol. 2016, 1, 133–146. [CrossRef]
7. Lee, Y.J.; Park, K.S. Irritable bowel syndrome: Emerging paradigm in pathophysiology. World J. Gastroenterol.
2014, 20, 2456–2469. [CrossRef] [PubMed]
8. Drossman, D.A. Functional gastrointestinal disorders: History, pathophysiology, clinical features, and Rome
IV. Gastroenterology 2016, 150, 1262–1279.e2. [CrossRef]
9. El-Salhy, M. Recent developments in the pathophysiology of irritable bowel syndrome. World J. Gastroenterol.
2015, 21, 7621–7636. [CrossRef]
10. Weaver, K.R.; Melkus, G.D.; Henderson, W.A. Irritable Bowel Syndrome. Am. J. Nurs. 2017, 117, 48–55.
[CrossRef]
11. Ng, Q.X.; Soh, A.Y.S.; Loke, W.; Lim, D.Y.; Yeo, W.-S. The role of inflammation in irritable bowel syndrome
(IBS). J. Inflamm. Res. 2018, 11, 345–349. [CrossRef] [PubMed]
12. Hayes, P.A.; Fraher, M.H.; Quigley, E.M.M. Irritable Bowel Syndrome: The Role of Food in Pathogenesis and
Management. Gastroenterol. Hepatol. 2014, 10, 164–174.
13. Morcos, A.; Dinan, T.; Quigley, E.M.M. Irritable bowel syndrome: Role of food in pathogenesis and
management. J. Dig. Dis. 2009, 10, 237–246. [CrossRef] [PubMed]
14. Böhn, L.; Störsrud, S.; Törnblom, H.; Bengtsson, U.; Simrén, M. Self-Reported Food-Related Gastrointestinal
Symptoms in IBS Are Common and Associated with More Severe Symptoms and Reduced Quality of Life.
Am. J. Gastroenterol. 2013, 108, 634–641. [CrossRef] [PubMed]
15. Ng, Q.X.; Soh, A.Y.S.; Loke, W.; Venkatanarayanan, N.; Lim, D.Y.; Yeo, W.-S. A Meta-Analysis of the Clinical
Use of Curcumin for Irritable Bowel Syndrome (IBS). J. Clin. Med. 2018, 7, 298. [CrossRef] [PubMed]
16. Brandt, L.J.; Chey, W.D.; Foxx-Orenstein, A.E.; Schiller, L.R.; Schoenfeld, P.S.; Spiegel, B.M.; Talley, N.J.;
Quigley, E.M. An evidence-based position statement on the management of irritable bowel syndrome. Am. J.
Gastroenterol. 2009, 104 (Suppl. 1), S1–S35. [PubMed]
17. Rao, S.S.C.; Yu, S.; Fedewa, A. Systematic review: Dietary fibre and FODMAP-restricted diet in the
management of constipation and irritable bowel syndrome. Aliment. Pharmacol. Ther. 2015, 41, 1256–1270.
[CrossRef] [PubMed]
18. Marsh, A.; Eslick, E.M.; Eslick, G.D. Does a diet low in FODMAPs reduce symptoms associated with
functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur. J. Nutr.
2016, 55, 897–906. [CrossRef] [PubMed]
19. Altobelli, E.; Del Negro, V.; Angeletti, P.M.; Latella, G. Low-FODMAP Diet Improves Irritable Bowel
Syndrome Symptoms: A Meta-Analysis. Nutrients 2017, 9, 940. [CrossRef]
Nutrients 2019, 11, 1313 10 of 12
20. Varjú, P.; Farkas, N.; Hegyi, P.; Garami, A.; Szabó, I.; Illés, A.; Solymár, M.; Vincze, Á.; Balaskó, M.; Pár, G.;
et al. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet
improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet:
A meta-analysis of clinical studies. PLoS ONE 2017, 12, e0182942. [CrossRef]
21. Schumann, D.; Klose, P.; Lauche, R.; Dobos, G.; Langhorst, J.; Cramer, H. Low fermentable, oligo-, di-,
mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and
meta-analysis. Nutrition 2018, 45, 24–31. [CrossRef] [PubMed]
22. McKenzie, Y.A.; Bowyer, R.K.; Leach, H.; Gulia, P.; Horobin, J.; O’Sullivan, N.A.; Pettitt, C.; Reeves, L.B.;
Seamark, L.; Williams, M.; et al. British Dietetic Association systematic review and evidence-based practice
guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J. Hum. Nutr.
Diet. 2016, 29, 549–575. [CrossRef] [PubMed]
23. National Institute for Health and Care Excellence Irritable Bowel Syndrome in Adults: Diagnosis and
Management|Guidance and Guidelines|NICE. In NICE Clinical Knowledge Summaries; NICE: London, UK, 2017;
Available online: https://www.nice.org.uk/guidance/cg61/chapter/1-Recommendations#more-information
(accessed on 20 September 2018).
24. O’Keeffe, M.; Lomer, M.C.E.E. Who should deliver the low FODMAP diet and what educational methods
are optimal: A review. J. Gastroenterol. Hepatol. 2017, 32, 23–26. [CrossRef] [PubMed]
25. Whelan, K.; Martin, L.D.; Staudacher, H.M.; Lomer, M.C.E. The low FODMAP diet in the management
of irritable bowel syndrome: An evidence-based review of FODMAP restriction, reintroduction and
personalisation in clinical practice. J. Hum. Nutr. Diet. 2018, 31, 239–255. [CrossRef] [PubMed]
26. Tuck, C.; Barrett, J. Re-challenging FODMAPs: The low FODMAP diet phase two. J. Gastroenterol. Hepatol.
2017, 32, 11–15. [CrossRef]
27. Barrett, J.S. How to institute the low-FODMAP diet. J. Gastroenterol. Hepatol. 2017, 32, 8–10. [CrossRef]
[PubMed]
28. Staudacher, H.M.; Lomer, M.C.E.; Farquharson, F.M.; Louis, P.; Fava, F.; Franciosi, E.; Scholz, M.; Tuohy, K.M.;
Lindsay, J.O.; Irving, P.M.; et al. A Diet Low in FODMAPs Reduces Symptoms in Patients with Irritable
Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Gastroenterology 2017, 153, 936–947. [CrossRef] [PubMed]
29. Staudacher, H.M.; Lomer, M.C.E.; Anderson, J.L.; Barrett, J.S.; Muir, J.G.; Irving, P.M.; Whelan, K. Fermentable
Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with
Irritable Bowel Syndrome. J. Nutr. 2012, 142, 1510–1518. [CrossRef]
30. Halmos, E.P.; Christophersen, C.T.; Bird, A.R.; Shepherd, S.J.; Gibson, P.R.; Muir, J.G. Diets that differ in their
FODMAP content alter the colonic luminal microenvironment. Gut 2015, 64, 93–100. [CrossRef]
31. Gearry, R.B.; Irving, P.M.; Barrett, J.S.; Nathan, D.M.; Shepherd, S.J.; Gibson, P.R. Reduction of dietary
poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with
inflammatory bowel disease-a pilot study. J. Crohn’s Colitis 2009, 3, 8–14. [CrossRef]
32. Koven, N.S.; Wabry, A. The clinical basis of orthorexia nervosa: Emerging perspectives. Neuropsychiatr. Dis.
Treat. 2015, 11, 385–394. [CrossRef] [PubMed]
33. Satherley, R.; Howard, R.; Higgs, S. Disordered eating practices in gastrointestinal disorders. Appetite 2014,
84, 240–250. [CrossRef] [PubMed]
34. Mari, A.; Hosadurg, D.; Martin, L.; Zarate-Lopez, N.; Passananti, V.; Emmanuel, A. Adherence with a
low-FODMAP diet in irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 2019, 31, 178–182. [CrossRef]
[PubMed]
35. de Roest, R.H.; Dobbs, B.R.; Chapman, B.A.; Batman, B.; O’brien, L.A.; Leeper, J.A.; Hebblethwaite, C.R.;
Gearry, R.B. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel
syndrome: A prospective study. Int. J. Clin. Pract. 2013, 67, 895–903. [CrossRef] [PubMed]
36. Staudacher, H.M.; Lomer, M.C.E.; Anderson, J.L.; Irving, P.M.; Whelan, K. Impact of a diet low in fermentable
carbohydrates on gastrointestinal symptoms, stool output and faecal pH in patients with irritable bowel
syndrome: A randomised controlled trial. Proc. Nutr. Soc. 2011, 70, E293. [CrossRef]
37. Yao, C.K.; Gibson, P.R.; Shepherd, S.J. Design of clinical trials evaluating dietary interventions in patients
with functional gastrointestinal disorders. Am. J. Gastroenterol. 2013, 108, 748–758. [CrossRef] [PubMed]
Nutrients 2019, 11, 1313 11 of 12
38. Department of Health. The Power of Information: Putting All of Us in Control of the Health and Care Information
We Need; Department of Health: London, UK, 2012.
39. Patient Information Forum. The Case for Information. Available online: https://www.pifonline.org.uk
(accessed on 10 November 2018).
40. Treadgold, P.; Grant, C. Evidence Review: What Does Good Health Information Look Like? Patient Information
Forum & Grant Riches Communication Consultants Ltd.: London, UK, 2014; Volume 2012, pp. 1–57.
41. Stenfanski, J. Dear Future Doctor . . . (2017). Available online: https://eatrightpa.org/members/blog/dear-
future-doctor/ (accessed on 23 October 2017).
42. Biggerstaff, D.L.; Thompson, A.R. Interpretative Phenomenological Analysis (IPA): A Qualitative
Methodology of Choice in Healthcare Research. Qual. Res. Psychol. 2008, 5, 214–224. [CrossRef]
43. Knowles, S.R.; Austin, D.W.; Sivanesan, S.; Tye-Din, J.; Leung, C.; Wilson, J.; Castle, D.; Kamm, M.A.;
Macrae, F.; Hebbard, G. Relations between symptom severity, illness perceptions, visceral sensitivity, coping
strategies and well-being in irritable bowel syndrome guided by the common sense model of illness. Psychol.
Health Med. 2016, 8506, 1–11. [CrossRef]
44. Wilpart, K.; Törnblom, H.; Svedlund, J.; Tack, J.F.; Simrén, M.; Van Oudenhove, L. Coping Skills Are
Associated with Gastrointestinal Symptom Severity and Somatization in Patients with Irritable Bowel
Syndrome. Clin. Gastroenterol. Hepatol. 2017, 15, 1565–1571.e3. [CrossRef]
45. Jakobsson Ung, E.; Ringstrom, G.; Sjövall, H.; Simrén, M. How patients with long-term experience of living
with irritable bowel syndrome manage illness in daily life. Eur. J. Gastroenterol. Hepatol. 2013, 25, 1478–1483.
[CrossRef]
46. Smith, J.A.; Osborn, M. Interpretative Phenomenological Analysis (IPA), 1st ed.; SAGE Publications Ltd.: London,
UK, 2007.
47. Tongco, M.D.C. Purposive Sampling as a Tool for Informant Selection. Ethnobot. J. 2007, 5, 147–158. [CrossRef]
48. Brocki, J.M.; Wearden, A.J. A critical evaluation of the use of interpretative phenomenological analysis (IPA)
in health psychology. Psychol. Heal. 2006, 21, 87–108. [CrossRef]
49. Kallio, H.; Pietilä, A.M.; Johnson, M.; Kangasniemi, M. Systematic methodological review: Developing a
framework for a qualitative semi-structured interview guide. J. Adv. Nurs. 2016, 72, 2954–2965. [CrossRef]
[PubMed]
50. Quinney, L.; Dwyer, T.; Chapman, Y. Who, Where, and How of Interviewing Peers: Implications for a
Phenomenological Study. SAGE J. 2016, 6. [CrossRef]
51. Smith, J.A.; Larkin, M.; Flowers, P. Interpretative Phenomenological Analysis: Theory, Method and Research; Sage:
London, UK, 2009.
52. Larkin, M.; Watts, S.; Clifton, E. Giving voice and making sense in interpretative phenomenological analysis.
Qual. Res. Psychol. 2006, 3, 102–120. [CrossRef]
53. Dionne, J.; Ford, A.C.; Yuan, Y.; Chey, W.D.; Lacy, B.E.; Saito, Y.A.; Quigley, E.M.M.; Moayyedi, P. A Systematic
Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in
Treating Symptoms of Irritable Bowel Syndrome. Am. J. Gastroenterol. 2018, 113, 1290–1300. [CrossRef]
54. Newbronner, L.; Chamberlain, R.; Borthwick, R.; Baxter, M.; Sanderson, D. Sustaining and Spreading
Self-Management Support—Lessons from Co-Creating Health Phase 2; Health Foundation: London, UK, 2013;
Volume 1, p. 84.
55. Catassi, C.; Elli, L.; Bonaz, B.; Bouma, G.; Carroccio, A.; Castillejo, G.; Cellier, C.; Cristofori, F.; Magistris, L.D.;
Dolinsek, J.; et al. Diagnosis of non-celiac gluten sensitivity (NCGS): The salerno experts’ criteria. Nutrients
2015, 7, 4966–4977. [CrossRef]
56. Staudacher, H.M.; Whelan, K. Altered gastrointestinal microbiota in irritable bowel syndrome and its
modification by diet: Probiotics, prebiotics and the low FODMAP diet. Proc. Nutr. Soc. 2016, 75, 306–318.
[CrossRef]
57. Food for Thought: The Role of Food in Romantic Relationships. Available online: http://thesis.honors.
olemiss.edu/id/eprint/637 (accessed on 14 March 2019).
58. Wong, R.K.; Drossman, D.A.; Weinland, S.R.; Morris, C.B.; Leserman, J.; Hu, Y.; Kelapure, R.; Bangdiwala, S.I.
Partner Burden in Irritable Bowel Syndrome. Clin. Gastroenterol. Hepatol. 2013, 11, 151–155. [CrossRef]
59. Williams, M. Are webinars the way forward for NHS patient education? Clin. Nutr. Foucs 2018, 10, 53–56.
Nutrients 2019, 11, 1313 12 of 12
60. Whigham, L.; Joyce, T.; Harper, G.; Irving, P.M.; Staudacher, H.M.; Whelan, K.; Lomer, M.C.E. Clinical
effectiveness and economic costs of group versus one-to-one education for short-chain fermentable
carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J. Hum. Nutr.
Diet. 2015, 28, 687–696. [CrossRef] [PubMed]
61. MONASH. Low FODMAP App. 2019. Available online: https://www.monashfodmap.com/ibs-central/i-
have-ibs/get-the-app/ (accessed on 23 May 2019).
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
